← Back to Search

Behavioral Intervention

BE-EHR module for Diabetes

N/A
Waitlist Available
Led By Andrea Troxel, ScD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 18
Awards & highlights

Study Summary

This trial will test a new electronic health record module that uses behavioral economics principles to improve care of older adults with diabetes, making it more compliant with Choosing Wisely guidelines.

Eligible Conditions
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 18
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 18 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Who Are CW-Compliant and CW-Noncompliant
Secondary outcome measures
Number of Total Prescription Encounters

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: standard EPIC instantiation plus the BE-EHR module.Experimental Treatment1 Intervention
The BE-EHR module includes six components: 1) a tailored advisory for patients over 75 with diabetes, 2) medication refill protocol with information on Choosing Wisely guidelines, 3) pre-population of the medication preference list with metformin, 4) lab result protocol with information on Choosing Wisely guidelines, 5) peer comparisons regarding performance meeting guidelines, and 6) media campaign with information about Choosing Wisely guidelines. The set of nudges is referred to collectively as the BE-EHR module.
Group II: standard EPIC instantiationActive Control1 Intervention
As per standard procedure at NewYorkUniversity Langone Health
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BE-EHR module
2020
N/A
~7630

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,013,295 Total Patients Enrolled
24 Trials studying Diabetes
757,296 Patients Enrolled for Diabetes
NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
833,005 Total Patients Enrolled
17 Trials studying Diabetes
12,622 Patients Enrolled for Diabetes
Andrea Troxel, ScDPrincipal InvestigatorNYU Langone
3 Previous Clinical Trials
54,580 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1761 spots leftby Apr 2025